Patent · US Expired

Isethionate salt of a selective CKD4 inhibitor

US7345171B2 · kind B2 · utility

55Cited by
2References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 6, 2004
Grant dateMar 18, 2008
Priority date
Expiry dateNov 29, 2025

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed are polymorphs of the isethionate salt of 6-acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-8H-pyrido[2,3-d]pyrimidin-7-one,which is a selective cyclin-dependent kinase 4 (CDK4) inhibitor useful for treating inflammation and cell proliferative diseases such as cancer and restenosis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.